Thndr Claps
  • U.S.
  • Egypt
  • Saudi
  • Thinkers
  • Arabic
No Result
View All Result
Thndr Claps

Thndr Claps » EGY Claps » Earnings 📈 » Rameda Announces Earnings; Molnupiravir Tablets💊

Rameda Announces Earnings; Molnupiravir Tablets💊

by Shams Abbas
February 27, 2022

Rameda (RMDA) has announced its earnings, as well as began commercial production of Molnupiravir medicine.

Rameda’s Earnings📈
The company reported a net profit of EGP 180.1 million in 2021, up 61.5% YoY.

The company’s revenues rose to EGP 1.25 billion, compared to EGP  960.17 million in 2020.

More on Molnupiravir
Molnupiravir is an oral medicine developed by “Merck” after receiving the necessary authorizations from the Egyptian Drug Authority (EDA), US Food and Drug Administration (USFDA) & UK’s Medicines & Healthcare Products Regulatory Agency (MHRA).

The company plans to release the first batch of “Molnupiravir” before the end of Q1 of this year at a price of EGP 625 per pack that contains 40 capsules.

  • Click to share on Facebook (Opens in new window)
  • Click to share on Twitter (Opens in new window)
  • Click to share on LinkedIn (Opens in new window)
  • Click to share on WhatsApp (Opens in new window)

Related Posts

دله للخدمات الصحية، تداول، السعودية
Tadawul 🔔

Dallah Health profits rise in Q2 🏥

by Omar El Shorafa
August 17, 2022
An ambitious plan for the Egyptian Modern Educational Systems🎓
Education 🏫

An ambitious plan for the Egyptian Modern Educational Systems🎓

by Ziad Amin
June 15, 2022
Novavax vaccine close to full authorization💉
Health & Pharma💉

Novavax vaccine close to full authorization💉

by Shams Abbas
June 9, 2022
Pfizer to invest more in its COVID pill💊
Health & Pharma💉

Pfizer to invest more in its COVID pill💊

by Shams Abbas
June 6, 2022
Tesla’s Shanghai factory back at 70% capacity🚗
Nasdaq 🔔

Tesla’s Shanghai factory back at 70% capacity🚗

by Shams Abbas
May 30, 2022
U.S. Q1-2022 GDP growth slightly worse than expected📉
Economy 🏙

U.S. Q1-2022 GDP growth slightly worse than expected📉

by Shams Abbas
May 27, 2022

Website

Community

Blog

Learn

© Thndr. All rights reserved

No Result
View All Result
  • U.S.
  • Egypt
  • Saudi
  • Thinkers
  • Arabic

Disclaimer: Thndr does not provide investment advice, individual investors are responsible for their own decisions or can seek independent advice. The value of investments can go up and down. Thndr is a trading name of Thndr Securities Brokerage which is authorised and regulated by the Financial Regulatory Authority (FRA). Registered in Egypt (no. 804)..© Thndr. All rights reserved

 

Hello👋 We want you to be able to express your opinions on anything and everything finance and economics related to the Egyptian and US markets.

This is why we introduced Thndr Thinkers💭

Let’s go through some housekeeping notes before you jump into publishing your article to all Thndr Claps readers!

Type of Content📝 We want to see market-relevant content that shows good analysis, please! Base your articles on facts 

Don’t be shy, explain🗣 Flex your knowledge to us, and we’ll share it with all the readers!

Be Original🙏 Please don’t copy. No one likes a copycat. All submissions are welcome as long as they’re yours 

Make your title attractive🤩 A title is like the cover of your book. Attractive enough to make you look at the book but also clear enough to tell you what the book is about.

Clean🧹 We’re all humans and we all make mistakes. But please try and clean up the article so it’s clear for all the readers 

No promotional content🚫 We don’t publish promotional content.

Any questions about becoming a Thndr Thinker? Email thndrclaps@thndr.app and we’d be happy to help!

Normally, your article will be published within 24 hours of submission (if you followed the guidelines)